본문으로 바로가기
현재 위치:
Home
진료과
비뇨의학과(암센터)
김광현
관심콘텐츠
프린트

의료진 소개

진료과 의료진
김광현 의사

김광현 교수

비뇨의학과, 암센터, 비뇨의학과(암센터), 로봇수술센터 관심의료진 등록

전문 진료 분야

전립선암/신장암 단일공 로봇수술, 비뇨기종양(전립선암, 방광암, 신장암, 신우요관암, 고환암 등), 로봇재건수술(신장 및 요관, 방광), 전립선비대증, 혈뇨 ※화(오전) 비뇨의학과(암센터) 진료는 전화예약만 가능합니다.

진료 일정

1522.7000 간편 예약 고맙습니다

학력사항

  • 연세대학교 의과대학 박사
  • 연세대학교 의과대학 석사
  • 연세대학교 의과대학 졸업

교육 및 연구경력

  • 2023-현재  | Hackensac University Medical Center, NJ (로봇수술 방문의사)
  • 2023-현재  | Naver Health Care Lab
  • 2019-현재  | 이대서울병원 비뇨의학과 조교수, 부교수
  • 2013-2019  | 이대목동병원 비뇨의학과 조교수
  • 2012-2013  | 연세대학교 의과대학 비뇨의학과 임상연구조교수
  • 2011-2012  | 서울아산병원 비뇨의학과 임상강사
  • 2007-2011  | 신촌세브란스 비뇨의학과 전공의 수료

수상경력

  • 2024 | KSER-ROUVICON Video Award
  • 2023 | 대한비뇨의학회 국외논문 우수상
  • 2023 | ICUrology, Most Cited Article Award
  • 2014 | Phamvio-Rowa 학술상
  • 2010 | EAU 우수포스터상

기타 학술 관련 경력

  • 2021-현재  | 대한비뇨의학회 고시위원
  • 2023-현재  | 대한비뇨내시경로봇학회 교육위원
  • 2023-현재  | 대한비뇨기종양학회이사
  • 2023-현재  | 대한전립선학회이사

논문

  •  Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection.  Experimental & Molecular Medicine. 2023 Nov;55(11):2445-2460. 
  •  Accurate detection of urothelial bladder cancer using targeted deep sequencing of urine DNA.  Cancers (Basel). 2023 May 22;15(10):2868. 
  •  Germline pathogenic variants in unselected Korean men with prostate cancer.  Investigative and clinical urology. 2022, v.63 no.3, 294-300. 
  •  Technique and perioperative outcomes of single-port robotic surgery using the da Vinci SP platform in urology.  Asian Journal of Surgery. 2022. 
  •  Urinary microbiome profile in men with genitourinary malignancies.  INVESTIGATIVE AND CLINICAL UROLOGY. 2022, v.63 no.5, 569-576. 
  •  Plasma osteoprotegerin levels are associated with the presence and burden of cerebral small vessel disease in patients with acute ischemic stroke.  CLINICAL NEUROLOGY AND NEUROSURGERY. 2021, v.210, 107010. 
  •  Ambulatory second look percutaneous nephrolithotripsy with maturated nephrostomy tract.  International Braz J Urol. 2020, v.46 no.4, 676-676. 
  •  Comparison of Four Commercial Kits for Isolation of Urinary Cell-Free DNA and Sample Storage Conditions.  DIAGNOSTICS. 2020, v.10 no.4, 234. 
  •  Single-port robot-assisted radical prostatectomy with the da vinci sp system: A single surgeon’s experience.  Investigative and Clinical Urology. 2020, v.61 no.2, 173-179. 
  •  Predictive factors for the development of renal insufficiency following partial nephrectomy and subsequent renal function recovery A multicenter retrospective study.  MEDICINE. 2019, v.98 no.18, e15516. 
  •  Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.  Investigative and Clinical Urology. 2019, v.60 no.6, 425-431. 
  •  esearch on Patient Satisfaction of Robotic Telerounding: A Pilot Study in a Korean Population.  Urology. 2019, v.130, 205-208. 
  •  Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma.  ONCOTARGET. 2018, v.9 no.1, 662-667. 
  •  Functional and oncological outcomes of open laparoscopic and robot-assisted partial nephrectomy: a multicentre comparative matched-pair analyses with a median of 5 years' follow-up.  BJU INTERNATIONAL. 2018, v.122 no.4, 618-626. 
  •  Impact of a change in duration of prophylactic antibiotics on infectious complications after radical cystectomy with a neobladder.  Medicine (Baltimore). 2018, v.97 no.47, e13196. 
  •  Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.  Sci Rep. 2018, v.8 no.1, 14707. 
  •  Role of bowel suspension technique to prevent early intestinal obstruction after radical cystectomy with ileal orthotopic neobladder: A retrospective cohort study.  Int J Surg. 2018, v.55, 9-14. 
  •  Functional and oncological outcomes of open, laparoscopic and robot-assisted partial nephrectomy: a multicentre comparative matched-pair analyses with a median of 5 years' follow-up..  BJU Int. 2018 Oct;122(4):618-626. 2018. 
  •  Clinical validation of serum endocan (ESM-1) as a potential biomarker in patients with renal cell carcinoma..  Oncotarget. 2018. 
  •  Cluster analysis identifies three urodynamic patterns in patients with orthotopic neobladder reconstruction.  PLoS One.2017 Oct 18;12(10):e0185255. 2017. 
  •  Impact of preoperative calculation of nephron volume loss on future of partial nephrectomy techniques; planning a strategic roadmap for improving functional preservation and securing oncological safety.  BJU Int. 2017 Nov;120(5):682-688.. 2017. 
  •  Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer.  Oncotarget. 2016 Sep 27;7(39):63252-63260. 2017. 
  •  Risk Factors for Developing Metabolic Acidosis after Radical Cystectomy and Ileal Neobladder.  PLoS One. 6;11(7):e0158220. 2016. 
  •  Febrile Urinary Tract Infection after Radical Cystectomy and Ileal Neobladder in Patients with Bladder Cancer..  J Korean Med Sci. 31(7):1100-4.. 2016. 
  •  Renoprotective Mechanism of Remote Ischemic Preconditioning Based on Transcriptomic Analysis in a Porcine Renal Ischemia Reperfusion Injury Model..  PLoS One. 21;10(10):e0141099.. 2015. 
  •  The prognostic effect of prostate-specific antigen half-life at the first follow-up visit in newly diagnosed metastatic prostate cancer..  Urol Oncol. 33(9):383.e17-22. 2015. 
  •  Preconditioning strategies for kidney ischemia reperfusion injury: implications of the "time-window" in remote ischemic preconditioning.  PLoS One. 10(4):e0124130. 2015. 
  •  Impact of metabolic syndrome on postdonation renal function in living kidney donors.  Transplant Proc. 47(2):290-4.. 2015. 
  •  Contralateral kidney volume change as a consequence of ipsilateral parenchymal atrophy promotes overall renal function recovery after partial nephrectomy.  Int Urol Nephrol. 47(1):25-32. 2015. 
  •  Clinical assessment of lipid profiles in live kidney donors.  Transplant Proc. 47(3):584-7. 2015. 
  •  Indenter study: associations between prostate elasticity and lower urinary tract symptoms.  Urology. 83(3):544-8. 2014. 
  •  Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era.  BJU Int. 113(4):598-604. 2014. 
  •  Less robot-assisted nephroureterecomy with conventional multiport technique in the management of upper urinary tract urothelial carcinoma.  BJU Int. 114(1):90-7. 2014. 
  •  Prospective measurement of urinary microalbumin in living kidney donor nephrectomy: toward understanding the renal functional recovery period.  J Urol. 192(4):1172-7. 2014. 
  •  Retzius-sparing robot-assisted laparoscopic radical prostatectomy: combining the best of retropubic and perineal approaches.  BJU Int. 114(2):236-44.. 2014. 
  •  Extended lymph node dissection in robot-assisted radical prostatectomy: lymph node yield and distribution of metastases.  Asian J. 2014. 
  •  A rare case of interparietal incisional hernia from 8 mm trocar site after robot-assisted laparoscopic prostatectomy.  Hernia. 18(6):911-3. 2014. 
  •  Intermediate-term outcomes of robot-assisted laparoscopic nephroureterectomy in upper urinary tract urothelial carcinoma.  Clin Genitourin Cancer. 11(4):515-21. 2013. 
  •  Yonsei criteria: a new protocol for active surveillance in the era of robotic and local ablative surgeries.  Clin Genitourin Cancer. 11(4):501-7. 2013. 
  •  Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.  Urol Oncol. 31(8):1643-9. 2013. 
  •  Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.  PLoS One. 8(11):e78049. 2013. 
  •  Gleason 5+4 has worse oncologic and pathological outcomes compared with Gleason 4+5: significance of Gleason 5 pattern.  Ann Surg Oncol. 20(9):3127-32. 2013. 
  •  Tumor volume adds prognostic value in patients with organ-confined prostate cancer.  Ann Surg Oncol. 20(9):3133-9.. 2013. 
  •  Robotic laparoendoscopic single-site transumbilical partial nephrectomy: functional and oncologic outcomes at 2 years.  Urology. 82(3):595-9. . 2013. 
  •  A modified technique for ureteral reimplantation: Intravesical detrusorrhaphy.  J Pediatr Surg. 48(8):1813-8. 2013. 
  •  Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.  BJU Int. 112(2):216-23.. 2013. 
  •  Upgrading of Gleason score and prostate volume: clinicopathological analysis.  BJU Int. 111(8):1310-6. 2013. 
  •  Feasibility of robotic laparoendoscopic single-site partial nephrectomy for renal tumors >4cm.  Eur Urol. 63(5):941-6. 2013. 
  •  Biochemical outcomes after robot-assisted radical prostatectomy in patients with follow-up more than 5-years.  Asian J Androl. 15(3):404-8. 2013. 
  •  Current status of robot-assisted laparoscopic radical prostatectomy: How does it compare with other surgical approaches? .  Int J Urol. 20(3):271-84. 2013. 
  •  Feasibility of Robotic Laparoendoscopic Single-Site Partial Nephrectomy for Renal Tumors >4cm.  Eur Urol . 2012 Nov 21. 
  •  Current status of robot-assisted laparoscopic radical prostatectomy: How does it compare with other surgical approaches?.  Int J Urol. 2012 Oct 29. 
  •  Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.  BJU Int. 2012 Sep 14. 
  •  Smoking and survival after radical cystectomy for bladder cancer.  Urology. 2012. 
  •  The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma.  J Cancer Res Clin Oncol. 2012; 138: 1561-7 . 
  •  Comparison of video-assisted minilaparotomy, open and laparoscopic partial nephrectomy for renal masses.  Yonsei Med J. 2012 Jan; 53(1): 151-7 . 
  •  Clinical course of vesicoureteral reflux in patients with hypospadias.  International Journal of Urology. 2012. 
  •  Clinical experiences of pheochromocytoma in Korea.  Yonsei Med J. 2011 Jan 1;52(1):45-50.